Gong SP - Search Results

1

[Diagnostic value of CA125, HE4 and Copenhagen Index in differentiating benign from malignant epithelial ovarian tumors].

Gong SP, Chen YN, Zhang YD, Yao W, Chen L, Liu SS, Wu H. Gong SP, et al. Nan Fang Yi Ke Da Xue Xue Bao. 2017 May 20;37(5):628-632. doi: 10.3969/j.issn.1673-4254.2017.05.10. Nan Fang Yi Ke Da Xue Xue Bao. 2017. PMID: 28539285 Free PMC article. Chinese.

2

Morbidity and risk factors for surgical site infection following cesarean section in Guangdong Province, China.

Gong SP, Guo HX, Zhou HZ, Chen L, Yu YH. Gong SP, et al. J Obstet Gynaecol Res. 2012 Mar;38(3):509-15. doi: 10.1111/j.1447-0756.2011.01746.x. Epub 2012 Feb 22. J Obstet Gynaecol Res. 2012. PMID: 22353388

3

[Value of serum cystatin C level in assessing renal damage in preeclamptic patients].

Gong S, Cai Y, Su G. Gong S, et al. Nan Fang Yi Ke Da Xue Xue Bao. 2013 Sep;33(9):1386-9. Nan Fang Yi Ke Da Xue Xue Bao. 2013. PMID: 24067226 Chinese.

4

[Relationship between pigment epithelium-derived factor expressed in placentas and the pathogenesis of preeclampsia disease].

Wu Y, Yu YH, Zhong M, Gong SP, Li Q, Liu SS. Wu Y, et al. Among authors: gong sp. Zhonghua Fu Chan Ke Za Zhi. 2013 Jul;48(7):490-3. Zhonghua Fu Chan Ke Za Zhi. 2013. PMID: 24284217 Chinese.

5

[Effects of estrogen on renal function of pregnant rabbits with hemorrhagic shock].

Liu S, Gong S, Wu H, Yang C, Liu Q, Huang Q, Yu Y. Liu S, et al. Nan Fang Yi Ke Da Xue Xue Bao. 2014 Feb;34(2):232-5. Nan Fang Yi Ke Da Xue Xue Bao. 2014. PMID: 24589603 Chinese.

6

[Protective effect of estrogen on acute lung injury after hemorrhagic shock in pregnant rabbit].

Wu H, Gong S, Liu S, Yao S, Liu Q, Yu Y. Wu H, et al. Zhonghua Fu Chan Ke Za Zhi. 2015 Jul;50(7):522-8. Zhonghua Fu Chan Ke Za Zhi. 2015. PMID: 26311643 Chinese.

7

[Effects of docosahexaenoic acid on cell apoptosis, invasion and migration of cervical cancer cells in vitro].

Yang C, Zhang GP, Chen YN, Meng FL, Liu SS, Gong SP. Yang C, et al. Among authors: gong sp. Nan Fang Yi Ke Da Xue Xue Bao. 2016 Jun;36(6):848-56. Nan Fang Yi Ke Da Xue Xue Bao. 2016. PMID: 27320891 Chinese.

8

Roflumilast restores cAMP/PKA/CREB signaling axis for FtMt-mediated tumor inhibition of ovarian cancer.

Gong S, Chen Y, Meng F, Zhang Y, Wu H, Wu F. Gong S, et al. Oncotarget. 2017 Dec 2;8(68):112341-112353. doi: 10.18632/oncotarget.22866. eCollection 2017 Dec 22. Oncotarget. 2017. PMID: 29348829 Free PMC article.

9

Roflumilast enhances cisplatin-sensitivity and reverses cisplatin-resistance of ovarian cancer cells via cAMP/PKA/CREB-FtMt signalling axis.

Gong S, Chen Y, Meng F, Zhang Y, Li C, Zhang G, Huan W, Wu F. Gong S, et al. Cell Prolif. 2018 Oct;51(5):e12474. doi: 10.1111/cpr.12474. Epub 2018 Aug 2. Cell Prolif. 2018. PMID: 30069985 Free PMC article.

10

RCC2, a regulator of the RalA signaling pathway, is identified as a novel therapeutic target in cisplatin-resistant ovarian cancer.

Gong S, Chen Y, Meng F, Zhang Y, Wu H, Li C, Zhang G. Gong S, et al. FASEB J. 2019 Apr;33(4):5350-5365. doi: 10.1096/fj.201801529RR. Epub 2019 Feb 15. FASEB J. 2019. PMID: 30768358

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

81 results

Search Page

Filters